| Methods |
Allocation concealment: NA
Blinding of study: no
Support: none declared |
| Participants |
100 participated total
Excluded: NA
Bone marrow transplantation, prophylactic |
| Interventions |
Fluconazole: 200 mg/d orally
Amphotericin B: 800 mg/d orally and 10 mg lozenges 4 times daily, and nystatin 200,000 IU mouthwash 6 times daily |
| Outcomes |
Positive culture
Use of escape drug |
| Notes |
Published as an abstract, no outcome data
Support: NA |
| Risk of bias |
| Bias |
Authors' judgement |
Support for judgement |
| Allocation concealment (selection bias) |
Unclear risk |
B ‐ Unclear |
| Blinding (performance bias and detection bias)
All outcomes |
High risk |
|
